OMIC NASDAQ
Singular Genomics Systems, Inc.
1W: +0.3%
1M: +0.6%
3M: -8.6%
1Y: +26.1%
3Y: -91.4%
$20.01
Last traded 2025-02-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3M
+280.5% ▲
Gross Profit
-$558K
-2225.0% ▼
Operating Income
-$103M
-10.0% ▼
Net Income
-$95M
-7.4% ▼
EPS (Diluted)
$-39.08
-5.0% ▼
EBITDA
-$86M
-2.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $765K | $3M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +280.5% |
| Cost of Revenue | $350K | $639K | $1M | $789K | $3M |
| Gross Profit | -$350K | -$639K | -$1M | -$24K | -$558K |
| Gross Margin | — | — | — | -3.1% | -19.2% |
| R&D Expenses | $10M | $21M | $33M | $46M | $48M |
| SG&A Expenses | $2M | $6M | $29M | $47M | $54M |
| Operating Expenses | $13M | $28M | $61M | $93M | $102M |
| Operating Income | -$13M | -$28M | -$61M | -$93M | -$103M |
| Operating Margin | — | — | — | -12220.5% | -3531.5% |
| Interest Expense | $17K | $718K | $846K | $763K | $1M |
| Income Before Tax | -$12M | -$28M | -$99M | -$91M | -$95M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$12M | -$29M | -$99M | -$88M | -$95M |
| Net Margin | — | — | — | -11538.7% | -3257.3% |
| EPS (Diluted) | $-5.34 | $-12.41 | $-40.95 | $-37.22 | $-39.08 |
| EBITDA | -$12M | -$27M | -$97M | -$84M | -$86M |
| Shares Outstanding | 2M | 2M | 2M | 2M | 2M |